Trial intelligence / Profile preview

AKK PROBIO in Obese Children and Adolescents

NCT07593170Phase 2Not yet recruiting

Sponsor
Central South University
Start
Jun 2026
Primary completion
Dec 2026
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

A Phase 2 trial of akkermansia muciniphila in obesity, sponsored by Central South University. Planned start Jun 2026; status: not yet recruiting.

02

Drugs

akkermansia muciniphila
03

Conditions

obesity

Beyond the preview

Go deeper on NCT07593170.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07593170.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call